Transactivation of the Epidermal Growth Factor Receptor Mediates Cholinergic Agonist-Induced Proliferation of H508 Human Colon Cancer Cells

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6744-6750

  Cheng, Kunrong ^a   Zimniak, Piotr ^b   Raufman, Jean Pierre ^a,c  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; AGS 1478; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; DNA 16S; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; N [4 (3 BROMOANILINO) 6 QUINAZOLINYL]ACRYLAMIDE; THROMBIN;

ARTICLE; CALCIUM CELL LEVEL; CANCER CELL; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; COLON CANCER; COMPLEX FORMATION; DRUG EFFECT; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACETYLCHOLINE; ANIMALS; ATROPINE; CELL DIVISION; CHO CELLS; CHOLINERGIC AGONISTS; COLONIC NEOPLASMS; CRICETINAE; DRUG INTERACTIONS; EGTAZIC ACID; FLAVONOIDS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCARINIC ANTAGONISTS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; TRANS-ACTIVATION (GENETICS); TYRPHOSTINS;

EID: 0142188718     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bonner, T., Buckley, N., Young, A., and Brann, M. Identification of a family of muscarinic acetylcholine receptor genes. Science (Wash. DC), 237: 527-532, 1987.
2. Brann, M. R., Ellis, J., Jorgenson, H., Hill-Eubanks, D., and Jones, S. V. Muscarinic acetylcholine receptor subtypes: localization and structure/function. Prog. Brain Res., 98: 121-127, 1993.
3. Slack, B. E. The m3 muscarinic acetylcholine receptor is coupled to mitogen-activated protein kinase via protein kinase C and epidermal growth factor receptor kinase. Biochem. J., 348: 381-387, 2000.
4. Frucht, H., Gazdar, A. F., Park, J-A., Oie, H., and Jensen, R. T. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res., 52: 1114-1122, 1992.
5. Frucht, H., Jensen, R. T., Dexter, D., Yang, W-L., and Xiao, Y. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Clin. Cancer Res., 5: 2532-2539, 1999.
6. Murphy, L. O., Cluck, M. W., Lovas, S., Otvos, F., Murphy, R. F., Schally, A. V., Permert, J., Larsson, J., Knezetic, J. A., and Adrian, T. E. Pancreatic cancer cell require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions. Br. J. Cancer, 84: 926-935, 2001.
7. Daub, H., Weiss, F. U., Wallasch, C., and Ullrich, A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature (Lond.), 379: 557-560, 1996.
8. Luttrcll, L. M., Della Rocca, G. J., van Biesen, T., Luttrcll, D. K., and Lefkowitz, R. J. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem., 272: 4637-4644, 1997.
9. Tsai, W., Morielli, A. D., and Peralta, E. G. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J., 16: 4597-4605, 1997.
10. Keely, S. J., Uribe, J. M., and Barrett, K. E. Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. Implications for carbachol-stimulated choride secretion. J. Biol. Chem., 27: 27111-27117, 1998.
11. src. J. Biol. Chem., 275: 12619-12625, 2000.
12. Schmidt, M., Huwe, S. M., Fasselt, B., Homann D., Rumenapp, U., Sandmann, J., and Jakobs, K. H. Mechanisms of phospholipase D stimulation by m3 muscarinic acetylcholine receptors. Evidence for involvement of tyrosine phosphorylation. Eur. J. Biochem., 225: 667-675, 1994.
13. Heimbrook, D. C., Stirdivant, S. M., Ahern, J. D., Balishin. N. L., Patrick, D. R., Edwards, G. M., Defco-Jones, D., FitzGerald, D. J., Pastan, I., and Oliff, A. Transforming growth factor α-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts. Proc. Natl. Acad. Sci. USA, 87: 4697-4701, 1990.
14. Skehan, P., Storeng, R., Scudicro, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokeseh, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. (Bethesda), 82: 1107-1112, 1990.
15. Seger, R., and Krebs, E. G. The MAPK signaling cascade. FASEB J., 9: 726-735, 1995.
16. Frodin, M., and Gammeltoft, S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol., 151: 65-77, 1999.
17. 2+ disturbances, and cell death in renal epithelial cells. J. Biol. Chem., 272: 21751-21759, 1997.
18. 2+ mobilization. Am. J. Physiol., 275: C832-C839, 1998.
19. Maccarronc, M., Lorenzon, T., Bari, M., Melino. G., and Finarzzi-Agro, A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem., 275: 31938-31945, 2000.
20. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
21. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem. J., 326: 1-16, 1997.
22. Levitzki, A., and Gazit, A. Tyrosine kinase inhibition: an approach to drug development. Science (Wash. DC), 267: 1782-1788, 1995.
23. Fry, D. W., Bridges, A. J., Denny, W. A., Doherty, A., Greis, K. D., Hicks, J. L., Hook, K. E., Keller, P. R., Leopold, W. R., Loo, J. A., McNamara, D. J., Nelson, J. M., Sherwood, V., Smaill, J. B., Trumpp-Kallmeyer, S., and Dobrusin. E. M. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. Proc. Natl. Acad. Sci. USA, 95: 12022-12027, 1998.
24. Rewcastle, G. W., Murray, D. K., Elliott, W. L., Fry, D. W., Howard, C. T., Nelson, J. M., Roberts, B. J., Vincent, P. W., Showalter, H. D., Winters, R. T., and Denny, W. A. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methyl-amino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors J. Med. Chem., 41: 742-751, 1998.
25. 1 for cell cycle progression induced by bombesin and bradykinin. Am. J. Physiol. Cell Physiol., 281: C886-C898, 2001.
26. Justman, Q. A., and Clinton, G. M. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest. J. Biol. Chem., 277: 20618-20624, 2002.
27. 13α signaling to NF-κB activation. J. Biol. Chem., 276: 31845-31850, 2001.
28. Lin, K., Wang, D., and Sadee, W. Serum response factor activation by muscarinic receptors via RhoA. Novel pathway specific to MI subtype involving calmodulin caleineurin, and Pyk2. J. Biol. Chem., 277: 40789-40798, 2002.
29. Rozengurt, E. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor. J. Cell. Physiol., 177; 507-517, 1998.
30. Vanhaesebroeck, B., and Alessi, D. R. The P13K-PDK1 connection: more than just a road to PKB. Biochem. J., 346: 561-576, 2000.
31. Vlahos, C. J., Matter, W. F., Brown, R. F., Traynor-Kaplan, A. E., Heyworth, P. G., Prossnitz, E. R., Ye, R. D., Marder, P., Schelm, J. A., Rothfuss, K. J., et al. Investigation of neutrophil signal transduction using a specific inhibitor of pbosphatidylinositol 3-kinase. J. Immunol., 154: 2413-2422, 1995.
32. Yano, H., Agatsuma, T., Nakanishi, S., Saitoh, Y., Fukui, Y., Nonomura, Y., and Matsuda, Y. Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fe ε R1-mediated signal transduction. Biochem. J., 312: 145-150, 1995.
33. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem., 269: 5241-5248, 1994.
34. Powis, G., Bonjouklian, R., Berggren, M. M., Gallegos, A., Abraham, R., Ashendel, C., Zalkow, L., Matter, W. F., Dodge, J., Grindey, G., et al. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res., 54: 2419-2423, 1994.
35. Okada, T., Sakuma, L., Fukui, Y., Hazeki, O., and Ui, M, Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269: 3563-3567, 1994.
36. Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., Woolf, S. H., Glick, S. N., Ganiats, T. G., Bond, J. H., Rosen, L., Zapka, J. G., and Olsen, S. J. Colorectal cancer screening:clinical guidelines and rationale. Gastroenterology, 112: 594-642, 1997.
37. Kinzler, D. W., and Vogelstein, B. Lessons from hereditary colorectul cancer. Cell, 87: 159-170, 1996.
38. Hill, M. J., Drasar, B. S., Williams, R. E., Meade, T. W., Cox, A. G., Simpson, J. E., and Morson, B. C. Faccal bile-acids and clostridia in patients with cancer of the large bowel. Lancet, 1: 535-539, 1975.
39. Reddy, B. S., Narasawa, T., Weisburger, J. H., and Wynder, E. L. Promoting effect of sodium deoxycholate on colon adenocarcinomas in germfree rats. J. Natl. Cancer Inst. (Bethesda), 56: 441-442, 1976.
40. Hill, M. J. Bile acids and colorectal cancer: hypothesis. Eur J. Cancer Prev., 1: 69-74, 1991.
41. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skylthe, A., and Hemminki, K. Environmental and heritable factors in the causation of cancer. N. Engl. J. Med., 343: 78-85, 2000.
42. Guizzetti, M., Costa, P., Peters, J., and Costa, L. G. Acetylcholine as a mitogcn: muscarinic receptor-mediated proliferation of rat astrocytes and human astrocytoma cells. Eur. Pharmacol., 297: 262-273, 1996.
43. Brown, J. H., Sah, V., Moskowitz, S., Ramirez, T., Collins, L., Post, G., and Goldstein, D. Pathways and roadblocks in muscarinic receptor-mediated growth regulation. Life Sci., 60: 1077-1084, 1997.
44. Eguchi, S., Numaguchi, K., Iwasaki, H., Matsumoto, T., Yamakawa, T., Utsunomiya, H., Motley, E. D., Kawakatsu, H., Owada, K. M., Hirata, Y., Marumo, F., and Inagami, T. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin 11-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem., 273: 8890-8896, 1998.
45. Zhang, L., and Jope, R. S. Muscarinic M3 and epidermal growth factor receptors activate mutually inhibitory signaling cascades in human neuroblastoma SH-SY5Y cells. Biochem. Biophys. Res. Commun., 255: 774-777, 1999.
46. Nicke, B., Dtjen, K., and Logsdon, C. D. Muscarinic cholinergic receptors activate both inhibitory and stimulatory growth mechanisms in NIH3T3 cells. J. Biol. Chem., 274: 21701-21706, 1999.
47. Daub, H., Wallasch, C., Lankenau, A., Herrlich, A., and Ullrich, A. Signal characteristic of G protein-transactivated EGF receptor. EMBO J., 16: 7032-7044, 1997.